Cargando…

Prevalence of dual contraceptive use and associated factors among HIV positive women at University of Gondar Hospital, Northwest Ethiopia

OBJECTIVE: Dual contraceptive is the use of male condom besides any modern contraceptive. It reduces parent to child transmission of HIV and other sexually transmitted infections between partners. The aim of this study was to investigate the prevalence and associated factors of dual contraceptive us...

Descripción completa

Detalles Bibliográficos
Autores principales: Reta, Mebratu Mitiku, Tessema, Gizachew Assefa, Shiferaw, Getachew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339424/
https://www.ncbi.nlm.nih.gov/pubmed/30658683
http://dx.doi.org/10.1186/s13104-019-4053-2
_version_ 1783388635961229312
author Reta, Mebratu Mitiku
Tessema, Gizachew Assefa
Shiferaw, Getachew
author_facet Reta, Mebratu Mitiku
Tessema, Gizachew Assefa
Shiferaw, Getachew
author_sort Reta, Mebratu Mitiku
collection PubMed
description OBJECTIVE: Dual contraceptive is the use of male condom besides any modern contraceptive. It reduces parent to child transmission of HIV and other sexually transmitted infections between partners. The aim of this study was to investigate the prevalence and associated factors of dual contraceptive use among HIV positive women at University of Gondar Hospital, North West Ethiopia. RESULT: The prevalence of dual contraceptive use was found to be 13.2% (95% CI 10.5, 16.0). Partner involvement in post-test counseling [AOR = 3.11 (95% CI = 1.74, 5.57)], open partner discussion on using dual contraceptive [AOR = 7.84, 95% CI (4.26, 14.42)], provision of counseling about dual contraception [AOR = 6.56, 95% CI (3.54, 12.18)], age 18–24 years [AOR = 4.79, 95% CI (1.72, 13.32)], age 25–34 years [AOR = 1.97, 95% CI (1.01, 3.85)] and being a housewife [AOR = 4.38, 95% CI (1.89, 10.16)] were significant factors associated with dual contraceptive use. The prevalence of dual contraceptive use was low. This shows, there is a need to in promote partner involvement in HIV testing and counseling by offering counseling session in a couple-basis. It is also necessary for programmers to routinely focus on provision of dual contraception for HIV-infected women and Integration of family planning into HIV care follow-up clinic need to be strengthened.
format Online
Article
Text
id pubmed-6339424
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63394242019-01-23 Prevalence of dual contraceptive use and associated factors among HIV positive women at University of Gondar Hospital, Northwest Ethiopia Reta, Mebratu Mitiku Tessema, Gizachew Assefa Shiferaw, Getachew BMC Res Notes Research Note OBJECTIVE: Dual contraceptive is the use of male condom besides any modern contraceptive. It reduces parent to child transmission of HIV and other sexually transmitted infections between partners. The aim of this study was to investigate the prevalence and associated factors of dual contraceptive use among HIV positive women at University of Gondar Hospital, North West Ethiopia. RESULT: The prevalence of dual contraceptive use was found to be 13.2% (95% CI 10.5, 16.0). Partner involvement in post-test counseling [AOR = 3.11 (95% CI = 1.74, 5.57)], open partner discussion on using dual contraceptive [AOR = 7.84, 95% CI (4.26, 14.42)], provision of counseling about dual contraception [AOR = 6.56, 95% CI (3.54, 12.18)], age 18–24 years [AOR = 4.79, 95% CI (1.72, 13.32)], age 25–34 years [AOR = 1.97, 95% CI (1.01, 3.85)] and being a housewife [AOR = 4.38, 95% CI (1.89, 10.16)] were significant factors associated with dual contraceptive use. The prevalence of dual contraceptive use was low. This shows, there is a need to in promote partner involvement in HIV testing and counseling by offering counseling session in a couple-basis. It is also necessary for programmers to routinely focus on provision of dual contraception for HIV-infected women and Integration of family planning into HIV care follow-up clinic need to be strengthened. BioMed Central 2019-01-18 /pmc/articles/PMC6339424/ /pubmed/30658683 http://dx.doi.org/10.1186/s13104-019-4053-2 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Note
Reta, Mebratu Mitiku
Tessema, Gizachew Assefa
Shiferaw, Getachew
Prevalence of dual contraceptive use and associated factors among HIV positive women at University of Gondar Hospital, Northwest Ethiopia
title Prevalence of dual contraceptive use and associated factors among HIV positive women at University of Gondar Hospital, Northwest Ethiopia
title_full Prevalence of dual contraceptive use and associated factors among HIV positive women at University of Gondar Hospital, Northwest Ethiopia
title_fullStr Prevalence of dual contraceptive use and associated factors among HIV positive women at University of Gondar Hospital, Northwest Ethiopia
title_full_unstemmed Prevalence of dual contraceptive use and associated factors among HIV positive women at University of Gondar Hospital, Northwest Ethiopia
title_short Prevalence of dual contraceptive use and associated factors among HIV positive women at University of Gondar Hospital, Northwest Ethiopia
title_sort prevalence of dual contraceptive use and associated factors among hiv positive women at university of gondar hospital, northwest ethiopia
topic Research Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339424/
https://www.ncbi.nlm.nih.gov/pubmed/30658683
http://dx.doi.org/10.1186/s13104-019-4053-2
work_keys_str_mv AT retamebratumitiku prevalenceofdualcontraceptiveuseandassociatedfactorsamonghivpositivewomenatuniversityofgondarhospitalnorthwestethiopia
AT tessemagizachewassefa prevalenceofdualcontraceptiveuseandassociatedfactorsamonghivpositivewomenatuniversityofgondarhospitalnorthwestethiopia
AT shiferawgetachew prevalenceofdualcontraceptiveuseandassociatedfactorsamonghivpositivewomenatuniversityofgondarhospitalnorthwestethiopia